Octave Bioscience raises $14 million for MS care management system in Series A round
BCBS Venture Partners leads round, with Section 32, Echo Health Ventures and others participating.
What was hot in cancer treatment innovation and precision medicine at MedCity CONVERGE? (Video)
If you missed our conference this week, fear not. We recorded some of the most interesting segments. Check them out.
presented by
5 Major Trends Emerging in Healthcare Benefits in 2025
Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better.
A Q&A with Foundation Medicine’s chairman-turned VC
Michael Pellini, the featured speaker at MedCity's CONVERGE conference next month, holds forth on his new VC gig at Bill Maris-founded Section 32, the practice of oncology, and how healthcare must get more tightly integrated with tech.